Friday, January 12, 2018 12:52:18 PM
Lets not forget that he purchased Alf at a fire sale for under $100 million because it failed to sell. Pope missed the boat and now he's doing his very best to push Alf under a new name(Senhance) but the market is not fooled. Just three or four people here. Listen, I am not bashing you people at all, just bashing Pop'e execution. The fire sale purchase of Alf is looking more and more likely that it will continue to fail as it did for many years.
His focus now has to be raising capital. Trxc has a massive monthly cash burn and 17 million in debt. The 100 million in the bank won't last very long at this rate. He needs to sell stock to keep the this thing going.
Would you agree that he should take a pay cut from the 2.2 million compensation he currently receives? I think that would show good faith but I don't think he will do that because I am sure the board of directors are realizing that Pope is not the man to steer this ship.
Recent ASXC News
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 04/29/2024 10:55:00 AM
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG • GlobeNewswire Inc. • 04/03/2024 12:45:00 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 10:55:00 AM
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference • GlobeNewswire Inc. • 02/28/2024 11:55:00 AM
- Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals • GlobeNewswire Inc. • 02/27/2024 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:01:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:00:04 AM
- Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 01/16/2024 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:55:21 AM
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update • GlobeNewswire Inc. • 01/08/2024 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:45:21 PM
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 11:55:00 AM
- Asensus Announces Sale of Senhance Robotic System in Romania • GlobeNewswire Inc. • 12/20/2023 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 11:26:08 PM
- Senhance Robotic System Sold by Asensus Surgical • GlobeNewswire Inc. • 12/04/2023 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:32 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023 • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Asensus Surgical Announces Sale of Senhance Robotic System • GlobeNewswire Inc. • 11/14/2023 11:55:00 AM
- Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System • GlobeNewswire Inc. • 11/13/2023 09:15:00 PM
- Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 11:55:00 AM
- Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 11/06/2023 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 10:55:13 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM